Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07155252 · ClinicalTrials.gov registry record

Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening

A clinical trial of Type 1 Diabetes, sponsored by Yale University.

Recruiting
Registry status
60
Enrollment target
1
Study location

NCT07155252 is a study of Type 1 Diabetes that is actively recruiting participants, run by Yale University. The registered enrollment target is 60 participants, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07155252, a study of Type 1 Diabetes, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
60 participants
Enrollment target
1
Study location

Study Summary

This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glucose tolerance test (OGTT) across a wide range of glycemic values in people at risk for clinical type 1 diabetes (T1D) (carriers of at least one islet autoantibody) or with new onset Stage 3 T1D within 100 days from the diagnosis.

Conditions Studied

Type 1 Diabetes

Interventions

  • DIAGNOSTIC_TEST GTT@Home

Study Locations (1)

Connecticut

  • Yale University Pediatric and Adult Diabetes Clinic - New Haven

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-08-26
Est. Completion 2027-09

Sponsor

Yale University

1,492 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07155252

The ClinicalTrials.gov registry entry for NCT07155252 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 824-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (93% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which GTT@Home is the first listed.

NCT07155252 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT07155252 about?

NCT07155252 is a clinical study titled "Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening". This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glucose tolerance test (OGTT) across a wide range of glycemic values in people at risk for clinical typ...

What is the current status of trial NCT07155252?

This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2025-08-26. Estimated completion is 2027-09.

What conditions does trial NCT07155252 study?

This clinical trial studies the following conditions: Type 1 Diabetes.

What interventions are being tested in trial NCT07155252?

The interventions under investigation include: GTT@Home (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07155252?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07155252 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 1 Diabetes

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.